United States will increase to more than 33 Million by the year end of 2022 | Aarkstore

North America Insulin Pump Market is likely to reach more than US$ 4.2 Billion by the year-end of 2022.







 Long-term Growth Projection:

  • The number of diabetes population in the United States will increase to more than 33 Million by the year-end of 2022

  • In 2016, there were more than 5,00,000 insulin pump users in the United States

  • Canada Insulin Pump market generated more than US$ 160 Million in 2016

  • The US is the major market share holder for the North America Insulin Pump Market

Increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle–compatible treatment options and technological advancement in insulin pump devices are the key factors driving the growth of the North America Insulin Pump Market. However, a high cost of the insulin pump devices is expected to hamper the growth of the market during the forecast period.

The report provides an in-depth analysis of type 1, type 2, newly diagnosed type 1 diabetes and overall diabetes population of all the three countries covered in the report. It provides essential insights of insulin pump users in terms of volume in detail for latest trends, outlook, and opportunities in all the three countries covered in the report.

Major Countries Covered in This Report:

  • United States
 • Canada
 • Mexico

  Major Companies Covered in This Report:

  • Insulet Corporation
 • Medtronic
 • Roche
 • Animas Corporation and
 • Tandem Diabetes Care
 • Microport
 • Sooil Development

For more inquiry contact our sales team at contact@aarkstore.com

Related Reports:





Contact Details:
Aarkstore Enterprise
Phone: +91 - 22 2756 4963
24/7 Online Support: +91 9987295242

Email: contact@aarkstore.com
Our website: https://www.aarkstore.com

Our blog: https://www.aarkstore.com/blog/

Comments

Popular posts from this blog

India travels across!

A detailed SWOT report on A.P. Moller – Maersk

Human Parainfluenza Virus 3 Infections, H1 2018